Sun, S., Hu, Y., Lan, L., Li, Y., Wu, Z., Deng, J., Bass, A. J., Zhao, Y., Liu, Z., Zhou, J. (2025). A phase I dose-escalation study to evaluate safety and feasibility of neoadjuvant camrelizumab with palbociclib for the treatment of resectable esophageal squamous cell carcinoma (ESCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e16114